COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Novo Nordisk A/S - Share repurchase programme26/02/2018
-   
  Medtronic Receives FDA Approval for New Arm Indication for Guardian(TM) Sensor 3 - Further Enhancing the MiniMed(TM) 670G Hybrid Closed Loop Experience26/02/2018
-   
  Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older26/02/2018
-   
  Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics for Subcutaneous Factor IX Product CB 2679d26/02/2018
-   
  Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference26/02/2018
-   
  K2M and International Spine Study Group Foundation Collaborate to Advance Data Management Using BACS®26/02/2018
-   
  Athenex, Inc. to Report Fourth Quarter and Full Year 2017 Earnings Results on March 26, 201826/02/2018
-   
  Profound Medical to Participate in 2018 BTIG Healthcare Conference26/02/2018
-   
  ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial26/02/2018
-   
  Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results26/02/2018
-   
  Clearside Biomedical Announces Organizational Changes Designed to Support Transition to a Commercial-Stage Company26/02/2018
-   
  Radient Technologies Inc. Announces Master Services Agreement with Medical Cannabis Supplier Bonify26/02/2018
-   
  Extendicare Announces Agreement to Acquire Lynde Creek Retirement Community26/02/2018
-   
  Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION Trial26/02/2018
-   
  Hemostemix Signs License Agreement with Aspire Health Science26/02/2018
-   
  PotNetwork Holding’s Diamond CBD Books Over $270,000 in Sales at CHAMPS Winter Show at Las Vegas Convention Center26/02/2018
-   
  Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Results26/02/2018
-   
  Strongbridge Biopharma plc Announces Underwriters’ Partial Exercise of Option to Purchase Additional Shares26/02/2018
-   
  SAVE THE DATE: Ninth Annual "Mardi Gras for Autism" Expects 4,000 Attendees at Fullerton Cares Event Raising Awareness for Autism – 4/7/201826/02/2018
Pages